-transparent.png){kind=logo}
The effect of cyclic somatostatin on circulating insulin levels was studied in eight patients with insulin-dependent diabetes mellitus (IDDM). The study was performed after an overnight fast when their subcutaneous depots of insulin had been depleted during i.v. insulin substitution for 18 hours. A constant rate i.v. insulin infusion (0.4 mU/kg/min) was given for 240 min and somatostatin was co-infused between 60-120 min (100 micrograms/h) and 180-240 min (250 micrograms/h) respectively. Plasma insulin, blood glucose and hematocrit were measured at 15 min intervals. Hematocrit fell from 41.7 to 38.3% during the study period. Somatostatin increased the plasma insulin levels, corrected for the changes of hematocrit, by approximately 8% in the low dose (P less than 0.05) as well as in the high dose (P less than 0.05) period. It is concluded that somatostatin interferes with the clearance of insulin thereby increasing the circulating plasma insulin levels in IDDM patients without residual insulin secretion.
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
January 1979,
Diabetes care,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
May 1997,
Coronary artery disease,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
February 2004,
Yonsei medical journal,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
June 1988,
Acta endocrinologica,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
September 1990,
Regulatory peptides,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
January 2016,
Internal medicine (Tokyo, Japan),
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
April 1998,
Endocrine journal,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
August 1992,
Journal of the Formosan Medical Association = Taiwan yi zhi,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
January 1984,
Problemy endokrinologii,
M Kollind, and
E Moberg, and
P E Lins, and
U Adamson
January 1999,
Journal of pediatric endocrinology & metabolism : JPEM,
